⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TNGX News
Tango Therapeutics, Inc.
Tango Therapeutics Appoints Sung Lee to Board of Directors
globenewswire.com
TNGX
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
TNGX
Tangoe Wins InfoWorld’s Technology of the Year Award 2025 for Cloud Cost Management
businesswire.com
TNGX
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
prnewswire.com
ONCY
IMRX
TNGX
MRNA
RPRX
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
TNGX
Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate
globenewswire.com
TNGX
Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
globenewswire.com
TNGX
Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
globenewswire.com
TNGX
Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
globenewswire.com
TNGX
Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025
globenewswire.com
TNGX